RRGB

The Beauty Health Co

Insider Buying -Interest rates may have peaked but the damage to earnings is just beginning

by

Market gains are muted, and traders are quick to snatch profits.  Rallies are reversed almost daily as market direction is indecisive.  By many measures, bargains in the stock market are hard to come by.  The earnings yield of the S&P 500 is 3.98%, and the P.E. is historically on the low side.  Earnings surprises are met with a sell-the-news trading mentality.  The economy is showing signs of stalling, yet the Fed has made it clear, that if rate hikes are near the end of the cycle, high-interest rates will be here for quite a while.  10% car loans and 7.3% … Read more

Insider Buying week 8-27-21

by

For trade, details click on this link to the trades.  I had a dream Friday morning about the stock market. I yelled out in my sleep, “everything is going up.” I woke up and it pretty much did exactly that. In a good market, almost all trades bounce sharply but the stickiness and real progress from there are what you have to measure. Perhaps deduct 4 or 5 percent from all the posted returns to determine your likely return as getting them at the same price or lower than the insider’s purchase cost is difficult to do since they almost … Read more

Notable Insider Buying Week 11-29-19

by

  Shares of Karuna Therapeutics Inc. KRTX, more than tripled (up 254%) November 19th in active trading to an intraday high of $123.99 after a phase 2 trial of its schizophrenia treatment met its primary endpoint.  Karuna and its underwriters, led by Goldman Sachs et al, wasted no time rushing out a sport secondary at $96 raising $250 million. At Friday’s close of $71.88, people lost serious money in this secondary, including biotech VC and hedge fund Sofinnova Venture Partners which upped their position by$15 million.  No tears shed as they are early investors, buying $15 million on the IPO at … Read more